I cannot see why this wouldn't happen TBH, The market cap at 20c would only show the money they would have after the initial payment, that wouldn't include any of the future payments, or the payments by Chiesi for Brontichol. Add up all these payments and the market cap share price equivalent would be around $1.08. Not including future royalties by Chiesi or by BI.
Ann: Boehringer Ingelheim acquires Pharmaxis phase 1 drug, page-16
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.82M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.0¢ | 3.0¢ | $85.29K | 2.843M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1120000 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 215622 | 1 |
View Market Depth
| Last trade - 11.31am 10/07/2024 (20 minute delay) ? |
| SNT (ASX) Chart |